City
Epaper

UK sees cases of deadly haemorrhagic fever with 'pandemic potential': Report

By IANS | Published: February 11, 2022 8:18 PM

London, Feb 11 The UK has detected a deadly haemorrhagic fever with "pandemic potential", the country's health officials ...

Open in App

London, Feb 11 The UK has detected a deadly haemorrhagic fever with "pandemic potential", the country's health officials have said.

Lassa fever is an acute viral haemorrhagic illness, similar to Ebola, and people become infected through exposure to food or other items that have been contaminated with urine or faeces of infected rats.

According to the UK Health Security Agency (UKHSA), the Lassa fever has been imported to the UK for the first time in a decade, the Telegraph reported. Previously, there have been eight cases of Lassa fever imported to the UK since 1980, with the last two cases occurring in 2009, the report said.

The agency announced two confirmed cases and one probable case of Lassa fever in the country.

The three affected patients all from the same family had recently returned from West Africa, where the disease is endemic and there is an ongoing outbreak, the report said.

While health officials have sounded a note of calm to dampen down fears of disease spread in the UK, "at the moment it is unclear if anyone else has been infected", Susan Hopkins, the chief medical adviser at the UKHSA, was quoted as saying.

"Cases of Lassa fever are rare in the UK and it does not spread easily between people. The overall risk to the public is very low. We are contacting the individuals who have had close contact with the cases prior to confirmation of their infection, to provide appropriate assessment, support and advice," Hopkins said.

The haemorrhagic fever can also spread from person to person through body fluids.

It has symptoms like flu fever, headaches, sore throat, muscle pain as well as diarrhoea and vomiting.

In severe cases it can cause bleeding from the vagina, mouth or nose and severe facial swelling.

In West Africa, there are around 100,000 cases of the disease a year with an average of 5,000 deaths. But some 80 per cent of cases are asymptomatic.

While there is no effective treatment or vaccine, two jabs have entered phase one trials in 2019 and another started human trials last year.

The disease has been classed as having pandemic potential and it is on the WHO's list of priority pathogens alongside viruses such as Ebola and dengue, the report said.

Lassa fever is a rare, but serious infection. But it's chances of a spread like Covid in the UK is "unlikely".

Dr Michael Head, a senior research fellow in global health at the University of Southampton, was quoted as saying.

"Whilst any Lassa cases within the UK are of concern, we won't be seeing transmission anything like the scale we have with the Covid-19 pandemic," Head said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: ukLondonTelegraphPremier of saMichael headAdministrative capitalSusan hopkinsUk health security agencyUk health security
Open in App

Related Stories

InternationalLondon Stabbing: 13-Year-Old Boy Killed, Four Injured in Sword Attack Near Tube Station

InternationalLondon Stabbing: Several Stabbed, Including Two Police Officers Near Hainault Tube Station; Scary Video of Man With Sword Goes Viral

InternationalLondon: Overseas Friends of Bjp UK Organises Spectacular ‘Run for Modi’ Event

InternationalLondon: Five Injured After Blood-Soaked Royal Horses Escape, Collide with Cars; Videos Go Viral

EntertainmentCheck Out: Alia Bhatt Is All Set To Host Her First ‘Hope Gala’ in London

Health Realted Stories

HealthWhy uncontrolled hypertension may be a significant health threat?

HealthChildren with severe obesity at age 4 may have a life expectancy of just 39: Study

HealthSouth Korea to regulate synthetic nicotine as tobacco through legislation

NationalBureau of Indian Standards Takes Steps To Simplify Hospital Bills

HealthJaipur child suffering from rare disease administered injection worth Rs 17.50 cr